Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung Su

Showing results (271-280 of 393) with videos related to

Pageof 40
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|November 12, 2019
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in TaiwanChen-Hua Liu, Chun-Jen Liu, Chien-Ching Hung, et al.
The Journal of Trauma and Acute Care Surgery|November 29, 2012
The Laboratory Risk Indicator for Necrotizing Fasciitis score for discernment of necrotizing fasciitis originated from Vibrio vulnificus infectionsWai-Nang Chao, Shih-Jei Tsai, Chin-Feng Tsai, et al.
Radiology|March 28, 2018
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral TherapyTung-Hung Su, Chun-Hsun Liao, Chen-Hua Liu, et al.
International Journal of Cancer|December 20, 2019
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancerTung-Hung Su, Tai-Chung Tseng, Chun-Jen Liu, et al.
American Journal of Cancer Research|July 10, 2023
High PIVKA-II level and ASAP score predict 1-year risk of hepatocellular carcinoma in non-cirrhotic chronic hepatitis B patientsYi-Cheng Lu, Tung-Hung Su, Tai-Chung Tseng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients With Chronic Hepatitis C Virus InfectionChen-Hua Liu, Yih-Sharng Chen, Sheoi-Shen Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 10, 2013
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patientsCheng-Yuan Peng, Tsung-Cheng Hsieh, Tsai-Yuan Hsieh, et al.
American Journal of Surgery|February 19, 2013
Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitisWai-Nang Chao, Chin-Feng Tsai, Horng-Rong Chang, et al.
The Oncologist|April 11, 2020
Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab EraChieh-Lung Cheng, Sheng-Chuan Huang, Jia-Hong Chen, et al.
The Journal of Infectious Diseases|November 13, 2014
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapyCheng-Chao Liang, Chen-Hua Liu, Chen-Shuan Chung, et al.
Pageof 40

Showing results (271-280 of 393) with videos related to

Sort By:
Pageof 40
Liver International : Official Journal of the International Association for the Study of the Liver|November 12, 2019
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in TaiwanChen-Hua Liu, Chun-Jen Liu, Chien-Ching Hung, et al.
The Journal of Trauma and Acute Care Surgery|November 29, 2012
The Laboratory Risk Indicator for Necrotizing Fasciitis score for discernment of necrotizing fasciitis originated from Vibrio vulnificus infectionsWai-Nang Chao, Shih-Jei Tsai, Chin-Feng Tsai, et al.
Radiology|March 28, 2018
Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral TherapyTung-Hung Su, Chun-Hsun Liao, Chen-Hua Liu, et al.
International Journal of Cancer|December 20, 2019
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancerTung-Hung Su, Tai-Chung Tseng, Chun-Jen Liu, et al.
American Journal of Cancer Research|July 10, 2023
High PIVKA-II level and ASAP score predict 1-year risk of hepatocellular carcinoma in non-cirrhotic chronic hepatitis B patientsYi-Cheng Lu, Tung-Hung Su, Tai-Chung Tseng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients With Chronic Hepatitis C Virus InfectionChen-Hua Liu, Yih-Sharng Chen, Sheoi-Shen Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 10, 2013
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patientsCheng-Yuan Peng, Tsung-Cheng Hsieh, Tsai-Yuan Hsieh, et al.
American Journal of Surgery|February 19, 2013
Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitisWai-Nang Chao, Chin-Feng Tsai, Horng-Rong Chang, et al.
The Oncologist|April 11, 2020
Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab EraChieh-Lung Cheng, Sheng-Chuan Huang, Jia-Hong Chen, et al.
The Journal of Infectious Diseases|November 13, 2014
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapyCheng-Chao Liang, Chen-Hua Liu, Chen-Shuan Chung, et al.
Pageof 40